FI963638A - Menetelmiä HIV-1-injektion diagnosoimiseksi ja hoitamiseksi - Google Patents
Menetelmiä HIV-1-injektion diagnosoimiseksi ja hoitamiseksi Download PDFInfo
- Publication number
- FI963638A FI963638A FI963638A FI963638A FI963638A FI 963638 A FI963638 A FI 963638A FI 963638 A FI963638 A FI 963638A FI 963638 A FI963638 A FI 963638A FI 963638 A FI963638 A FI 963638A
- Authority
- FI
- Finland
- Prior art keywords
- hiv
- infection
- diagnosis
- procedures
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Rehabilitation Therapy (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21374394A | 1994-03-14 | 1994-03-14 | |
PCT/US1995/003236 WO1995025124A1 (en) | 1994-03-14 | 1995-03-13 | Methods to diagnose and treat hiv-1 infection |
Publications (2)
Publication Number | Publication Date |
---|---|
FI963638A0 FI963638A0 (fi) | 1996-09-13 |
FI963638A true FI963638A (fi) | 1996-11-13 |
Family
ID=22796323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI963638A FI963638A (fi) | 1994-03-14 | 1996-09-13 | Menetelmiä HIV-1-injektion diagnosoimiseksi ja hoitamiseksi |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0750636A1 (fi) |
JP (1) | JPH10504798A (fi) |
CA (1) | CA2185129A1 (fi) |
FI (1) | FI963638A (fi) |
NO (1) | NO963848L (fi) |
WO (1) | WO1995025124A1 (fi) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2358385C (en) | 1998-12-31 | 2013-08-06 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
EP1411770A4 (en) | 2001-07-05 | 2006-05-10 | Chiron Corp | POLYNUCLEOTIDES CODING FOR ANTIGENIC C-TYPE HIV POLYPEPTIDES, POLYPEPTIDES AND THEIR USE |
JP4108601B2 (ja) * | 2001-09-06 | 2008-06-25 | サントル・ナシオナル・ドゥ・ラ・ルシェルシュ・シアンティフィク | 修飾ペプチドおよび自己免疫疾患を治療するためのその使用 |
TW200726479A (en) | 2005-04-12 | 2007-07-16 | Univ Duke | Method of inducing neutralizing antibodies to human immunodeficiency virus |
CN101588813A (zh) * | 2005-04-12 | 2009-11-25 | 杜克大学 | 诱导人类免疫缺陷病毒的中和抗体的方法 |
WO2008127651A1 (en) | 2007-04-13 | 2008-10-23 | Duke University | Method of inducing neutralizing antibodies to human immunodeficiency virus |
CA2757240A1 (en) | 2009-04-03 | 2010-10-07 | Duke University | Formulation for inducing broadly reactive neutralizing anti-hiv antibodies |
US10076567B2 (en) | 2013-09-27 | 2018-09-18 | Duke University | MPER-liposome conjugates and uses thereof |
US10213482B2 (en) | 2014-12-12 | 2019-02-26 | Immupharma France Sa | Methods of treating chronic inflammatory diseases |
-
1995
- 1995-03-13 CA CA002185129A patent/CA2185129A1/en not_active Abandoned
- 1995-03-13 JP JP7524156A patent/JPH10504798A/ja not_active Ceased
- 1995-03-13 EP EP95914049A patent/EP0750636A1/en not_active Withdrawn
- 1995-03-13 WO PCT/US1995/003236 patent/WO1995025124A1/en not_active Application Discontinuation
-
1996
- 1996-09-13 FI FI963638A patent/FI963638A/fi not_active IP Right Cessation
- 1996-09-13 NO NO963848A patent/NO963848L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
FI963638A0 (fi) | 1996-09-13 |
AU694204B2 (en) | 1998-07-16 |
CA2185129A1 (en) | 1995-09-21 |
WO1995025124A1 (en) | 1995-09-21 |
AU2120595A (en) | 1995-10-03 |
EP0750636A1 (en) | 1997-01-02 |
NO963848L (no) | 1996-11-14 |
JPH10504798A (ja) | 1998-05-12 |
NO963848D0 (no) | 1996-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI952926A0 (fi) | Menetelmät allergioiden hoitamiseksi tai ehkäisemiMenetelmät allergioiden hoitamiseksi tai ehkäisemiseksi seksi | |
FI971969A (fi) | Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä | |
NO952573D0 (no) | Blandinger for behandling av diabetiske komplikasjoner | |
FI963281A (fi) | Ureaasipohjainen rokote ja helicobakteeri-infektion hoito | |
DE69822410D1 (de) | Modularkatheter zur Abbildung und Behandlung und Montageverfahren | |
FI970918A0 (fi) | Yhdisteet ja menetelmät syövän hoitamiseksi | |
FI94028B (fi) | Laite nenäsairauksien diagnoosia ja hoitoa varten | |
FI19992398A (fi) | Menetelmä ja järjestely sydämen lyönnin tunnistamiseksi | |
DE69115626D1 (de) | Medizinisches Gerät für endoskopische Chirurgie | |
DE69522448D1 (de) | Gewebebehandlungskassette | |
FI951370A (fi) | Tiatsolidinin ja oksatsolidinin johdannaiset, niiden valmistus ja lääkinnällinen käyttö | |
DE69529307D1 (de) | Ultraschall-Diagnose- und Behandlungssystem | |
DE69635364D1 (de) | Blutfilter und extrakorporaler Kreislauf | |
FI971568A (fi) | Menetelmä resistenttien kasvainten hoitamiseksi | |
AU6579498A (en) | Compounds and methods for the diagnosis and treatment of (ehrlichia) infection | |
FI965204A (fi) | Bromelaiinin lääkekäyttö | |
DE69620691D1 (de) | Therapeutisches Mittel zur Behandlung der Hypercholesterinämie | |
BR9101494A (pt) | Tratamento de tecidos | |
FI963638A (fi) | Menetelmiä HIV-1-injektion diagnosoimiseksi ja hoitamiseksi | |
ATA113492A (de) | Mehrfachbeutelsystem zur sterilen behandlung von menschlichen blutkonserven | |
FI971897A0 (fi) | Ihmisen retrovirusinfektion detektointi | |
NO913117L (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
FI953087A (fi) | Selluloosa-aineen käsittely ja siinä käytettävät koostumukset | |
FI964113A0 (fi) | Lääkekoostumus hoitamaan tardiivia dyskinesiaa ja sen käyttö | |
NO965591D0 (no) | Kombinasjonsbehandling av HIV-infeksjon |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MA | Patent expired |